Angion Biomedica Corp. Common Stock

Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool. Appreciate Holdings, Inc. (NASDAQ: SFR) rose 60% to $0.3221. Elevation Oncology, Inc. (NASDAQ: ELEV) shares jumped 52.2% to $4.58 after adding over 15% on Thursday. Alarum Technologies Ltd. (NASDAQ: ALAR) rose 31.6% to $2.87. Bright Health Group, Inc. (NYSE: BHG) climbed 32% to $10.66. Verastem, Inc. (NASDAQ: VSTM) gained 30% to $0.5847. Verastem highlighted updated data from Part A of RAMP 201 trial. MediaAlpha, Inc. (NYSE: MAX) gained 27.4% to $9.68 after White Mountains Insurance Group, Ltd. and WM Hinson commenced a tender offer for up to 5 million shares of MediaAlpha stock. Marvell Technology, Inc. (NASDAQ: MRVL) rose 27.1% to $62.85 after the company reported strong first-quarter results and said it expects AI revenue to at least double in 2024. Arcus Biosciences, Inc. (NYSE: RCUS) shares climbed 25.8% to $22.01. Citigroup maintained Arcus Biosciences with a Buy. Telos Corporation (NASDAQ: TLS) gained 18.3% to $3.09. iTeos Therapeutics, Inc. (NASDAQ: ITOS) climbed 17.9% to $16.38. eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares surged 17% to $0.6190 as the company reported data updates from Phase 2 expansion cohorts evaluating zotatifin in patients with ER+ metastatic breast cancer at the ASCO 2023 Annual Meeting. PDD Holdings Inc. (NASDAQ: PDD) gained 16.3% to $69.83 after the company reported better-than-expected Q1 financial results. Stryve Foods, Inc. (NASDAQ: SNAX) gained 16.3% to $0.82. ENDRA Life Sciences Inc. (NASDAQ: NDRA) climbed 14.7% to $1.5135. PDS Biotechnology Corporation (NASDAQ: PDSB) rose 13.5% to $7.64. PDS Biotechnology announced ...

Related tickers: GPCR, VSTM, TLRY, ELEV, XYF, VIEW, PDSB, PDD, SKIN, SPCE, AEY, SNAX, ITOS, GERN, HIBB, RH, DSGN, MRVL, ANGN, DLO, ONCY, USDP, BHG, ULTA, GCT, EFTR, BMR, TLS, ELBM, GPS, DOMO, HSCS, ROC, SFR, SBIG, SAI, MAX, ONFO, SDA, NDRA, SHPH, CAN, PAGS, WLDS, ALAR, NA, RCUS.

Gainers Oncorus, Inc. (NASDAQ: ONCR) shares rose 90% to $0.38 in pre-market trading after dropping around 17% on Thursday. Oncorus recently posted a narrower-than-expected quarterly loss. eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares surged 67.6% to $0.8866 in pre-market trading as the company reported data updates from Phase 2 expansion cohorts evaluating zotatifin in patients with ER+ metastatic breast cancer at the ASCO 2023 Annual Meeting. Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) gained 45.4% to $1.73 in pre-market trading after dropping 8% on Thursday. Shuttle Pharmaceuticals was recently granted U.S. patent #11654157: Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation. Arcus Biosciences, Inc. (NYSE: RCUS) gained 26.5% to $22.14 in pre-market trading. Arcus Biosciences announced new employment inducement grants. Harbor Custom Development, Inc. (NASDAQ: HCDI) shares gained 24.1% to $4.64 in pre-market trading. Harbor Custom Development recently issued an update on the Company’s six multi-family projects. Elevation Oncology, Inc. (NASDAQ: ELEV) ...

Related tickers: ONCR, IFBD, EFTR, MRVL, PRSO, BMR, SHPH, GPS, WLDS, SDA, NA, ELEV, EVOK, ANGN, RCUS, TLRY, XYF, PDSB, LIZI, HCDI.